Jan 20, 2026
BioXcel Therapeutics Submits Supplemental New Drug Application to U.S. Food and Drug Administration for IGALMI® Label Expansion in the At-Home SettingVIEW RELEASE
Jan 12, 2026
BioXcel Therapeutics Expands Leadership Team to Prepare for Launch of IGALMI® in the At-Home SettingVIEW RELEASE
Jan 07, 2026
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®VIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
Jan 28, 2026 04:00 PM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
1.68
CHANGE
0 (0%)
